Dr. Lal PathLabs Schedules Board Meeting to Review FY26 Financial Results
Dr. Lal PathLabs Ltd. announced that a board meeting is scheduled for Thursday, April 30, 2026, to review and approve the audited standalone and consolidated financial results for the quarter and financial year ending March 31, 2026.In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company’s code for prevention of insider trading, the trading window for securities of Dr. Lal PathLabs will be closed from April 1, 2026, to May 2, 2026, inclusive.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.